Some justices may be skeptical of a bid by GSK, Pfizer and others to overturn ruling allowing lawsuits to proceed over claims ...

UnitedHealth has traditionally been a company investors saw as reliable, having not missed earnings estimates since the 2008 global financial crisis.

Significant delays in core FDA functions — such as approving amendments to clinical trials and guiding companies through ...

The Trump administration is considering eliminating dozens of programs at HHS amid a mass reorganization of the agency.

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

When Novartis announced it was teaming up with the NFL last month, the company called it the first-ever corporate pharmaceutical partnership with the league. But it wasn’t exactly the only matchup ...

A key group of government advisers voted to expand the use of vaccines for a common respiratory illness, providing a boost to ...

Welcome to CureVac fourth-quarter and full year 2024 financial results and business update call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

The Global Active Pharmaceutical Ingredients Market achieved a valuation of $209.80 Billion in 2024 and is anticipated to ...

With a portfolio containing a number of vaccines, GSK has been working for some years on the question of adult vaccination and why immunisation rates are falling, particularly in those over 50 ...